NZ310561A - Immunosuppressant of the aromatic variety based upon the quinoline family - Google Patents

Immunosuppressant of the aromatic variety based upon the quinoline family

Info

Publication number
NZ310561A
NZ310561A NZ310561A NZ31056196A NZ310561A NZ 310561 A NZ310561 A NZ 310561A NZ 310561 A NZ310561 A NZ 310561A NZ 31056196 A NZ31056196 A NZ 31056196A NZ 310561 A NZ310561 A NZ 310561A
Authority
NZ
New Zealand
Prior art keywords
immunosuppressant
variety based
aromatic
quinoline family
quinoline
Prior art date
Application number
NZ310561A
Other languages
English (en)
Inventor
Takashi Sohda
Yoshikazu Ohta
Haruhiko Makino
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NZ310561A publication Critical patent/NZ310561A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ310561A 1995-09-13 1996-06-19 Immunosuppressant of the aromatic variety based upon the quinoline family NZ310561A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23570495 1995-09-13
PCT/JP1996/001693 WO1997009984A1 (en) 1995-09-13 1996-06-19 Immunosuppressant

Publications (1)

Publication Number Publication Date
NZ310561A true NZ310561A (en) 1999-07-29

Family

ID=16990000

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ310561A NZ310561A (en) 1995-09-13 1996-06-19 Immunosuppressant of the aromatic variety based upon the quinoline family

Country Status (10)

Country Link
EP (1) EP0850061A1 (pt)
KR (1) KR19990044618A (pt)
CN (1) CN1195988A (pt)
AU (1) AU6137396A (pt)
BR (1) BR9610314A (pt)
CA (1) CA2226915A1 (pt)
HU (1) HUP9900169A2 (pt)
NO (1) NO980788L (pt)
NZ (1) NZ310561A (pt)
WO (1) WO1997009984A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941987A1 (de) * 1998-03-13 1999-09-15 Lonza A.G. Verfahren zur Herstellung von 2-Amino-4,5,3',4'-tetramethoxybenzophenon
EP1277740A1 (en) * 1998-06-12 2003-01-22 Vertex Pharmaceuticals Incorporated Inhibitors of p38
AU4429799A (en) 1998-06-12 1999-12-30 Vertex Pharmaceuticals Incorporated Inhibitors of p38
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
PL1663197T3 (pl) 2003-09-09 2008-09-30 Biogen Idec Int Gmbh Zastosowanie pochodnych kwasu fumarowego do leczenia niewydolności serca oraz astmy
EP4137819A1 (en) 2007-02-08 2023-02-22 Biogen MA Inc. Compositions and uses for treating multiple sclerosis
CN102050780B (zh) * 2010-11-18 2012-05-02 中国科学院昆明植物研究所 喹啉衍生物,其药物组合物及其用途
WO2017151947A1 (en) * 2016-03-02 2017-09-08 George Robert Pettit 4-azapodophylotoxins compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633471B2 (en) * 1987-08-26 1993-02-04 Biogen Idec Ma Inc. Biological materials, processes for producing biological materials and for using such materials in therapy
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
JP2863265B2 (ja) * 1989-05-19 1999-03-03 ハダサ メディカル オーガニゼーション インターロイキン１インヒビター
US6238875B1 (en) * 1991-03-12 2001-05-29 The Scripps Research Institute Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1
TW232013B (pt) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
EP0664128A4 (en) * 1992-10-07 1997-12-17 Sumitomo Pharma PHARMACEUTICAL AGENT FOR INHIBITING TUMORNESCROSE FACTOR PRODUCTION.
JPH06340658A (ja) * 1993-04-08 1994-12-13 Kyowa Hakko Kogyo Co Ltd ベンゾイミダゾール誘導体
IL111743A0 (en) * 1993-12-08 1995-01-24 Intermune Life Sciences Inc Recombinant genes expressing pp14

Also Published As

Publication number Publication date
NO980788L (no) 1998-03-31
CN1195988A (zh) 1998-10-14
HUP9900169A2 (hu) 2000-03-28
AU6137396A (en) 1997-04-01
BR9610314A (pt) 1999-07-06
KR19990044618A (ko) 1999-06-25
EP0850061A1 (en) 1998-07-01
CA2226915A1 (en) 1997-03-20
WO1997009984A1 (en) 1997-03-20
NO980788D0 (no) 1998-02-25

Similar Documents

Publication Publication Date Title
IL128729A0 (en) Annular catheter
AU7847098A (en) The preparation of enantiomerically-enriched threo- methylphenidate
ZA979731B (en) Treatment of asthma.
EP1017459A4 (en) GAME OF CHANCE
EP0920622A4 (en) DETECTION OF MICROBACTERIA
AU3552697A (en) Novel treatment of leptine resistance
NZ310561A (en) Immunosuppressant of the aromatic variety based upon the quinoline family
GR3026571T3 (en) Preparation of 2-H-heptafluoropropane.
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
GB9602704D0 (en) Structure of perculator
ZA973843B (en) Treatment of asthma with TNFR-lg.
GB9304403D0 (en) Manufacture of partially aromatic polyamides
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
GB9503259D0 (en) Lawnmowers
EP0639579A3 (en) Preparation of metallocenes.
ZA975001B (en) Preparation of Alpha-fluoroketones.
ZA975061B (en) Manufacture of articles.
GB9706184D0 (en) Match of the day
HU9401650D0 (en) Family house of the new type
ZA979045B (en) Derivates of pentaerythrits.
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
ZA9610076B (en) The securing of premises
ZA9711206B (en) The preparation of enantiomerically-enriched threo-methyl-phenidate
PL305421A1 (en) Aromatic derivatives of pinocamphone